A calprotectin stool test detects levels of calprotectin in stool. This protein indicates bowel inflammation. It can help diagnose and monitor conditions such as inflammatory bowel disease (IBD). A ...

Measurement of faecal calprotectin concentration is increasingly used to assess disease activity in patients with IBD. Lasson et al. have now demonstrated that calprotectin concentrations in faeces of ...

New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue of ...

July 22, 2010 — A new approach to the diagnosis of inflammatory bowel disease (IBD) — fecal calprotectin testing — is a useful tool for identifying patients who are most likely to need endoscopy for ...

New York, United States , June 22, 2024 (GLOBE NEWSWIRE) -- The Global Fecal Calprotectin Test Market Size is to Grow from USD 126.15 Million in 2023 to USD 366.15 Million by 2033, at a CAGR of 11.24% ...

A simple screening test identifies patients who are most likely to have inflammatory bowel disease and reduces the need for expensive, invasive and time consuming endoscopies, finds a new study. A ...

Of 575 patients enrolled in the study, 538 (94%, 248 male, 290 female) were included in the final analysis (Figure 1). Thirty-seven patients (6.4%) were excluded; 6 patients for incomplete endoscopy ...

The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...

The global fecal calprotectin test market is on a trajectory of substantial growth, with projections estimating an increase from USD 68 million in 2023 to USD 160 million by 2031, reflecting a ...